Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...

TOKYO (AP) — Japanese technology company SoftBank Group Corp. reported a 369.2 billion yen ($2.4 billion) loss for the fiscal ...

Car manufacturers are increasingly using subscriptions and paywalled features to generate revenue, but some tactics are ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

The South Carolina Manufacturers Alliance (SCMA) has officially launched the fourth annual Manufacturing Madness: Coolest ...

It omits the type of risk information that drug manufacturers are required to provide in direct-to-consumer ads and fails to clearly disclose that compounded drugs aren’t FDA-approved ...

Duracell, one of the world’s leading battery manufacturers, unveiled its first-ever creative ad spot during the big game on Sunday. The brand shocked ...

A class-action lawsuit filed against Gore-Tex accuses the company of deceiving buyers and concealing the chemicals used in ...

The Protecting America Initiative tackles the issue in the ad by reminding viewers that President Donald Trump in 2019 had ...